Drug · DIN 02417316
APO-CICLESONIDE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since January 20, 2020; first marketed November 25, 2016.
- Drug Identification Number (DIN)
- 02417316
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Spray (Metered-Dose)
- Route
- Nasal
- Therapeutic class (ATC)
- Ciclesonide R01AD13
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CICLESONIDE | 50 MCG | ACT |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 1, 2015: NOC 16859Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “apo-ciclesonide”. A notice may cover another product or only some lots: read it to see what it covers.
- APO-CICLESONIDE (2017-08-31)November 14, 2017 · Drugs · Product safety · Type II